NEW YORK, March 27 – Database and bioinformatics company GeneData said Tuesday it entered a multi-year collaboration to supply its Phylospher comparative genomics software for the study of pathogens to Novartis Pharma, extending a relationship between the two companies that began three years ago.
In February, GeneData announced that Novartis had licensed its Expressionist microarray data analysis system.